A BRAVE York schoolboy undergoing pioneering and potentially life saving cancer treatment has been discharged from hospital.
Seven-year-old Jamie Inglis has been allowed to leave hospital to stay with his parents, Vicky and John, as he continues specialist treatment for the childhood cancer neuroblastoma as an outpatient in Tubingen near Stuttgart.
It is significant progress for the the Lord Deramore’s Primary School pupil, who has been in hospital since August where he was given a stem cell transplant from his father to give him a donor-derived immune system to help him fight the cancer.
Jamie initially spent four weeks in a sealed isolation room and has spent the past few weeks in a hospital room hooked to an IV line for pain relief and food supplements while medics waited for him to recover sufficiently and for Jamie to start eating again.
The family is currently working to raise £250,000 to pay for the the medical trial, which has not been funded by the NHS and is believed by oncologists to be his best chance of survival.
Mr Inglis said: “We had our first outpatient appointment on Wednesday and they are very pleased with his recovery. We got all his blood results and everything is looking really good. They said he is doing remarkably well.”
Mr Inglis said Jamie had been enjoying his freedom by looking for spiders outside the hospital-owned property provided for the parents of patients.
While the Inglis family could return home within the next couple of weeks – which would mean Jamie would be able to see his three-year-old sister, Poppy, for the first time in two months – travelling through a busy airport and on a plane could jeopardise Jamie’s health by leaving his vulnerable immune system open to infection.
The family and their supporters are currently appealing for help with a private flight back home, like that which allowed fellow patient Vanessa Riddle to return home to Scotland.
If he is able to return home, Jamie is expected to travel back to Germany once a month when his immune system is a little stronger, for antibody treatment which will attack the tumour cells.